Hathaway Pease Russell

Registered Patent Attorney

I partner with clients to secure their innovations and provide IP strategies that further their key business objectives.

Hathaway Pease Russell practices intellectual property law with a focus on the life sciences industry. She has extensive experience assisting pharmaceutical companies, start-up biotechnology companies, established biopharmaceutical corporations and academic institutions with worldwide patent portfolio management, competitive landscape analyses, freedom-to-operate assessments, due diligence evaluations of patent portfolios, patent opinion, and investigation and resolution of inventorship disputes.

Hathaway has over 20 years of experience in intellectual property matters. She focuses on the areas of life sciences, especially in the fields of immunology, biochemistry, pharmacogenomics, proteomics, and disease biomarkers, and their application to personalized medicine. Hathaway has developed world-wide patent strategies to protect drug products in the market with multi-billion annual sales, and she has conducted IP due diligence for multiple multi-million dollar transactions. She collaborates with the firm's Government Strategies Group on regulatory matters, including initiatives by the FDA in the area of advanced diagnostics. She also works with the Litigation Group and has filed amicus briefs in the U.S. Supreme Court in numerous cases including Mayo Collaborative Services and Mayo Clinic Rochester v. Prometheus Laboratories, Inc.

In addition to her practice, Hathaway has lectured on patenting strategies at national and international conferences. She is an active member of the American Intellectual Property Law Association (AIPLA) and has played a significant role in advancing AIPLA’sWomen in IP Committee.


  • Baylor School of Law, J.D., 2000
  • Bowdoin College, B.A. in Neuroscience, magna cum laude, 1996

Bar and Court Admissions


  • Massachusetts
  • Texas


  • U.S. Patent & Trademark Office (Agency)


  • Spanish


  • Management of blockbuster drug portfolio
  • Management of personalized medicine patent portfolios
  • Active engagement with the U.S. Patent and Trademark Office interviewing patent cases
  • Advised on patent strategy and policy issues for venture-backed Coalition of advanced diagnostics companies
  • Amicus briefs to Supreme Court in Mayo Collaborative and Mayo Clinic Rochester v. Prometheus Laboratories and Association for Molecular Pathology v. Myriad Genetics, Inc. cases
  • Speaks regularly at U.S. Patent and Trademark Office 
  • Provided non-infringement patent opinions in electrochemical industry


  • AIPLA comments on behalf of the Biotechnology Committee on proposed rules of practice pertaining to "Revision to the Time for Filing of a Biological Deposit and the Date of Availability of a Biological Deposit" (April 2008)
  • Assisted in drafting accepted application entitled "A Case Study of a Biotechnology-Related Action Before the International Trade Commission" for BIO (2008)
  • AIPLA comments on behalf of the Biotechnology Committee on the proposed rules of practice pertaining to claims using alternative language (October 2007)

Honors & Involvement

  • Listed as a ‘Rising Star’ in Intellectual Property, Super Lawyers’ Massachusetts Rising Stars: A Comprehensive Listing of the Best Young Lawyers in Massachusetts (2011 - 2014) 
  • American Intellectual Property Law Association (AIPLA)
    • Chair Women in IP Committee, October 2013-2017
    • Vice-Chair Women in IP Committee, October 2011-2013
    • Vice-Chair Education Committee, October 2009-October 2011
    • Chair Women's National Networking Event, October 2009-October 2015
    • Chair of Subcommittee of Legislative Policy for Biotechnology Committee
  • Pro Bono matters for Boston Housing Authority
  • Participates as a coach for VC 101 for Center for Women & Enterprise
  • Boston Patent Law Association, Member
  • American Bar Association, Member

Speaking Engagements

  • “Managing Your IP Portfolio: The In-House Perspective,” Rocky Mountain Intellectual Property & Technology Law Conference (June 2022)
  • “Recent Developments in Patent Subject Matter Eligibility under 35 U.S.C. 101,” North Carolina Bar Association IP Section’s Annual CLE Symposium (March 2015)
  • “Recent Supreme Court Case Law & Implications for Medical Device and Diagnostic Industries,” Medical Device and Diagnostics IP/Patent Strategy Conference (March 2015)
  • "The Impact of the America Invents Act on Innovations," The Forsyth Institute (April 2013)
  • Public Hearing on Genetic Testing, USPTO (January 2013)
  • "Intellectual Property Issues for Diagnostics," Genome-wide Partnering & Deal-making Conference (May 2012)
  • "Personalized Medicine: Intellectual Property Protection, FDA Regulation and Reimbursement," AUTM 2012 (March 2012)
  • "Diagnostics - The Changing IP and Regulator Landscape," G2 Intelligence’s Molecular Diagnostics Conference (April 2011)
  • "Genetics in the Regulatory & Policy Realm," 3rd Annual Consumer Genetics Conference (June 2011)
  • "Using the Internet For Litigation and Prosecution in the New Information Age” (February 2011)
  • “Teaching Children About Patent Law and Innovation” (February 2011)
  • “Understanding the Implications of the Rapidly Evolving U.S. Healthcare and Regulatory Environment," AusBiotech 2010 (October 2010)
  • "Maintaining and Gaining Career, Momentum in Spite of the Economic Downturn," American Intellectual Property Law Association (January 2010)
  • Co-Organizer, Consumer Genetics Conference (June 2010 and June 2009)
  • "Overview of the Requirements for Patentability," AIPLA Boot Camp: 2008 Practical Patent Prosecution Training for New Lawyers (August 2009 and August 2008)
  • “Making Sense of the Data and Explaining It to the Consumer," Consumer Genetics Conference (June 2009)
  • "Genetics and the Law: Intellectual Property, Regulation and Public Policy," Consumer Genetics Conference (June 2009)
  • "Protecting Your Business" (June 2009)